About Index Trending news
Analyze
Pricing
The Column Group

The Column Group

Elsewhere

Alexa global traffic share

Investment profile

Target markets
Biotechnology

Activity

Past year's investments

- The Column Group participated in 5 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $168,800,000 (averaging $33,760,000 per round).

Latest rounds

- Effector Therapeutics: Venture capital (Series C) ($38.6M)
- Peloton Therapeutics: Undisclosed funding ($22.2M)
- Surrozen: Venture capital (Series A) ($33M)

Main Co-investors

- Altitude Life Science Ventures
- Third Rock Ventures
- Osage University Partners

Total funding
$187.2M in 5 rounds from 16 investors
By The Column Group
$55M Venture Capital in Dec, 2015
Total funding
$295.4M in 5 rounds from 13 investors
By The Column Group
$26.6M Series A in Dec, 2009
Total funding
$142.4M in 3 rounds from 15 investors
By The Column Group
$52.4M Series D in Sep, 2016
Total funding
$83.6M in 2 rounds from 19 investors
By The Column Group
$38.6M Series C in Jul, 2017
Total funding
$53.2M in 2 rounds from 4 investors
By The Column Group
$38M Series B in Dec, 2014
Exit Bristol-Myers Squibb, Feb 23, 2015
Total funding
$99M in 4 rounds from 15 investors
By The Column Group
$49M Series C in Oct, 2013
Total funding
$50M in 1 rounds from 4 investors
By The Column Group
$50M Series B in Apr, 2016
Total funding
$70M in 1 rounds from 9 investors
By The Column Group
$70M Series B in Sep, 2016
Total funding
$92.6M in 4 rounds from 10 investors
By The Column Group
$22.2M Undisclosed funding in Mar, 2017
Total funding
$70M in 2 rounds from 3 investors
By The Column Group
$25M Series A in Dec, 2016
Total funding
$50M in 1 rounds from 1 investors
By The Column Group
$50M Series A in Dec, 2016
Total funding
$33M in 1 rounds from 1 investors
By The Column Group
$33M Series A in Feb, 2017

Want to see the complete list?
Go Pro!